Raises Guidance Strong

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Business - MarketWatch - October 30

Meta's third-quarter profit surges 35% reflecting strong ad revenue and its AI push

Meta Platforms Inc. has posted stronger-than-expected third-quarter results fueled by its advertising revenue growth and its push to incorporate artificial intelligence

Tech - ABC News - October 30

Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.

Business - CNBC - 6 days ago

Apple looks strong on AI; Amazon rules the cloud. Earnings will show how much.

Expect positive surprises from these two “Magnificent Seven” standouts.

Business - MarketWatch - 6 days ago

Third-party candidates could be swing-state spoilers despite strong Democrat efforts

Less than a week before Election Day, third-party candidates still present an unknown factor in key swing states where dozens of Electoral College votes are up for grabs.

Latest in Raises Guidance Strong

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Meta's third-quarter profit surges 35% reflecting strong ad revenue and its AI push

Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall

Apple looks strong on AI; Amazon rules the cloud. Earnings will show how much.

Third-party candidates could be swing-state spoilers despite strong Democrat efforts

Topics